Lilly + Prime Therapeutics Push the Envelope on Next Generation Value-based Agreements
Lilly has partnered with Prime Therapeutics to explore how value-based arrangements (VBA’s) can be used to improve patient outcomes while [...]
AMCP Collaborate Platform Enhances Collaboration to Support and Inform Managed Care Pharmacy
AMCP Collaborate is a platform for AMCP members to connect and share ideas and solutions about the most vexing challenges [...]
Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020 Just Released
Intellectual Research Partners has released the Health Economics & Outcomes Research (HEOR) Services Market Research Report 2020.The report details the [...]
Optum leverages natural language processing system (NLP) to provide oncology- related insights
Making data available to researcher through extracting essential information from oncological medical records is one of Optum’s key oncology data [...]
Key Innovations Coming From The Next Generation of PBM’s
The world of pharmacy benefit management (PBM) will change dramatically over the next five years and much of the change is coming from [...]
What Does $11M in Donations to Congress Buy Pharma?
Pharmaceutical manufacturers and trade groups have recently contributed $11 million and cut 4,500 checks to Congressional lawmakers ahead of the [...]
Eversana Partners on Research Data Assessment
Eversana, a global life-sciences commercial services firm, is partnering with the Institute for Clinical and Economic Review (ICER) to promote [...]
Stanford Center for Health Education Launches Online Program in AI and Healthcare.
A new program launched by the Stanford Center for Health Education aims to advance the delivery of patient care and [...]
PRMA Consulting Announces New Singapore Office and Virtual Open House
Jayne Sykes, Partner at PRMA Consulting, announces a new office opening in Singapore and explains how the company is shaping [...]
OM1 Insights: How We Use AI to Find Rare Disease Patients
"Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack", according to [...]
2 of 3 Americans Reveal Healthcare Insecurity and Problems Paying for Prescription Drugs
The COVID-19 pandemic has caused severe healthcare insecurity for millions of Americans, according to CoverMyMeds’ 2020 Medication Access Report. As [...]
BCBSA Exec Aronson Calls for Desperately Needed Validated Outcome Measures for Coverage Decisions
Naomi Aronson, Executive Director for Clinical evaluation at the Blue Cross and Blue Shield Association, didn't mince words in a [...]
NPC Comments on NQF’s Draft Report on Patient-reported Outcomes (PROs)
The National Quality Forum (NQF) released a draft report on June 1, 2020 entitled "Patient-Reported Outcomes: Best Practices on Selection [...]
Global Experiences: Use of HTA for Health Benefit Packages Development, an ISPOR webinar
Health technology assessment (HTA) is increasingly used to inform universal health coverage (UHC), including financing and priority setting for benefit [...]
Real-world Evidence Put to the Test: Medicare’s New Codes for Remdesivir
The Centers for Medicare & Medicaid Services (CMS) has created new ICD-10-PCS procedure reimbursement codes to facilitate the generation of [...]
FDA Commissioner: COVID-19 Vaccine Must Adhere to Standards for Safety and Efficacy
Stephen Hahn, commissioner of the Food and Drug Administration penned an editorial in the August 5 issue of The Washington [...]
COVID-19 Vaccine Pricing: Are the Manufacturers Signaling their Intent?
The Wall Street Journal is reporting that vaccine manufacturers are signaling the price for coronavirus vaccines, with prices ranging from [...]
Patient Drug Costs Increased as Health Plans Promote Deductibles and Coinsurance, Says IQVIA Study
A decade ago, most patients were responsible for only their copay on a brand medication. However, the past few years [...]
Real-world Data Takes Center Stage in COVID-19 Response: Evidence Accelerator Community Tool Featured in Webinar by DIA
A webinar on "Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator" is taking place on Tuesday, [...]
RWE Challenges in Latin America featured in ISPOR Webinar on 10 August
The ISPOR Latin America Consortium Industry Committee is presenting a webinar "The Usage of Real-World Evidence (RWE): Monitoring and Managing [...]
Gilead Pricing of Remdesivir is “Immoral”, Says Pennsylvania’s Treasurer
Joe Torsella, Pennsylvania's elected treasurer, has come out swinging, calling Gilead Sciences "immoral" for their efforts to wring profit out [...]
Invoke a 1980’s Law to Lower Cost of Remdesivir for COVID-19, says 31 State Attorneys General
A coalition of attorneys general (AG) have requested the U.S. Department of Health and Human Services to invoke a federal [...]
Are You Making the Most of your Observational Data? How to Create a Synthetic Control from Your Natural History Study
In this blog from Cytel, a biostatistics and operations research provider, a case study is presented showing how real world [...]
Reminder: ICER webinar on Pricing in a Pandemic, Friday August 7
Session 3 in the ICER Colloquium Series entitled "Pricing in a Pandemic: Options, Debate, a Path Forward | Monetary Prizes, [...]
Trump’s “Buy American” Executive Order Could Raise Drug Prices
Tensions escalate with pharma as President Trump signs an executive order (EO) today directing the federal government to buy certain [...]